Current Edition About Subscribe The Jerusalem Center

Daily Alert Archive

Every Daily Alert Since 2002

Search

Search more than 90,000 news items by topic, author, or source.
Use " " to search for multiple words and phrases.

Trending Topics

May 21, 2021       Share:    

Source: https://en.globes.co.il/en/article-cystic-fibrosis-treatment-co-splisense-raises-285m-1001371009#utm_source=RSS

Israeli Cystic Fibrosis Restorative Treatment Company Splisense Raises $28.5 Million

(Globes) Israeli biopharmaceutical cystic fibrosis treatment developer Splisense announced on May 13 that it has closed a $28.5 million financing round. The Jerusalem-based company is developing mRNA-altering therapies for cystic fibrosis (CF) and other genetic pulmonary diseases. "Currently available treatments focus on treating the symptoms of the disease," said SpliSense CEO Dr. Gili Hart. "Our technology addresses the underlying genetic cause, thereby offering, for the first time, hope of restoring adequate lung function to CF patients."

View the full edition of Daily Alert

Back to Archive

Subscribe to Daily Alert: